Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' LHOMME C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lhomme, C; Brault, PH; Bourhis, JH; Pautier, P; Dohollou, N; Dietrich, PY; Akbar-Zadeh, G; Lucas, C; Pico, JL; Hayat, M
      Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: A pilot study

      LEUKEMIA & LYMPHOMA
    2. Morice, P; Levy-Piedbois, C; Ajaj, S; Pautier, P; Haie-Meder, C; Lhomme, C; Duvillard, P; Castaigne, D
      Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer

      EUROPEAN JOURNAL OF CANCER
    3. Morice, P; Pautier, P; Delaloge, S; Camatte, S; Spatz, A; Chompret, A; Lhomme, C; Duvillard, P; Castaigne, D
      Surgical management for prophylactic oophorectomy in women with an inherited risk of ovarian cancer

      TUMORI
    4. Pautier, P; Ghione, S; Brailly-Tabard, S; Lhomme, C; Morice, P; Bidart, JM
      Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?

      HUMAN REPRODUCTION
    5. Mateus, C; Fortier-Beaulieu, M; Lhomme, C; Rochard, F; Castaigne, D; Duvillard, P; Avril, MF
      Basal cell carcinoma of the vulva: 21 cases

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    6. Morice, P; Chapelier, A; Dartevelle, P; Castaigne, D; Lhomme, C
      Late intracaval and intracardiac leiomyomatosis following hysterectomy forbenign myomas treated by surgery and GnRH agonist

      GYNECOLOGIC ONCOLOGY
    7. Wagenaar, HC; Colombo, N; Vergote, I; Hoctin-Boes, G; Zanetta, G; Pecorelli, S; Lacave, AJ; van Hoesel, Q; Cervantes, A; Bolis, G; Namer, M; Lhomme, C; Guastalla, JP; Nooij, MA; Poveda, A; di Palumbo, VS; Vermorken, JB
      Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC Gynaecological Cancer Cooperative Group study

      GYNECOLOGIC ONCOLOGY
    8. Rouzier, R; Morice, P; Haie-Meder, C; Lhomme, C; Avril, MF; Duvillard, P; Castaigne, D
      Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas

      GYNECOLOGIC ONCOLOGY
    9. Morice, P; Lassau, N; Pautier, P; Haie-Meder, C; Lhomme, C; Castaigne, D
      Retroperitoneal drainage after complete paraaortic lymphadenectomy for gynecologic cancer: A randomized trial

      OBSTETRICS AND GYNECOLOGY
    10. Morice, P; Wicart-Poque, F; Rey, A; El-Hassan, J; Pautier, P; Lhomme, C; de Crevoisier, R; Haie-Meder, C; Duvillard, P; Castaigne, D
      Results of conservative treatment in epithelial ovarian carcinoma

      CANCER
    11. Ansquer, Y; Leblanc, E; Clough, K; Morice, P; Dauplat, J; Mathevet, P; Lhomme, C; Scherer, C; Tigaud, JD; Benchaib, M; Fourme, E; Castaigne, D; Querleu, D; Dargent, D
      Neoadjuvant chemotherapy for unresectable ovarian carcinoma - A French multicenter study

      CANCER
    12. Kerbrat, P; Lhomme, C; Fervers, B; Guastalla, JP; Thomas, L; Tournemaine, N; Basuyau, JP; Cohen-Solal, C; Duvillard, P; Bachelot, T; Ray, I; Voog, E; Dauplat, J
      Ovarian cancer

      BRITISH JOURNAL OF CANCER
    13. Resbeut, M; Fondrinier, E; Fervers, B; Haie-Meder, C; Bataillard, A; Lhomme, C; Asselain, B; Basuyau, JP; Bremond, A; Castaigne, D; Dubois, JB; Houvenaeghel, G; Lartigau, E; Leblanc, E; Sastre-Garaud, X; Ternier, F; Guastalla, JP; Chauvergne, J
      Carcinoma of the cervix

      BRITISH JOURNAL OF CANCER
    14. Morice, P; Haie-Meder, C; Rey, A; Pautier, P; Lhomme, C; Gerbaulet, A; Duvillard, P; Castaigne, D
      Radiotherapy and radical surgery for treatment of patients with bulky stage IB and II cervical carcinoma

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    15. Lhomme, C; Vermorken, JB; Mickiewicz, E; Chevalier, B; Alvarez, A; Mendiola, C; Pawinski, A; Lentz, MA; Pecorelli, S
      Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

      EUROPEAN JOURNAL OF CANCER
    16. Andre, F; Fizazi, K; Culine, S; Droz, JP; Taupin, P; Lhomme, C; Terrier-Lacombe, MJ; Theodore, C
      The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

      EUROPEAN JOURNAL OF CANCER
    17. Delaloge, S; Pautier, P; Kerbrat, P; Castaigne, D; Haie-Meder, C; Duvillard, P; Guivarch, C; Goupil, A; Borel, C; Lhomme, C
      Neuroendocrine small cell carcinoma of the uterine cervix: What disease? What treatment? Report of ten cases and a review of the literature

      CLINICAL ONCOLOGY
    18. Kerbrat, P; Lhomme, C; Fervers, B; Guastalla, JP; Thomas, L; Basuyau, JP; Duvillard, P; Cohen-Solal, C; Dauplat, J; Tournemaine, N
      Standards, Options and Recommendations for initial management of patients with a malignant epithelial ovarian tumor

      PRESSE MEDICALE
    19. Delaloge, S; Morice, P; Chompret, A; Lhomme, C
      Prophylactic surgery: Oophorectomy or adnexectomy?

      JOURNAL OF CLINICAL ONCOLOGY
    20. Delaloge, S; Laadem, A; Taamma, A; Chouaki, N; Cvitkovic, E; Pautier, P; Misset, JL; Lhomme, C
      Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    21. Mrad, K; Morice, P; Fabre, A; Pautier, P; Lhomme, C; Duvillard, P; Sabourin, JC
      Krukenberg tumor: a clinico-pathological study of 15 cases

      ANNALES DE PATHOLOGIE
    22. Joly, F; Heron, JF; Kerbrat, P; Chauvergne, J; Rios, M; Mayer, F; Chinet-Charrot, P; Goupil, A; Lebrun-Jezekova, D; Vennin, D; Lhomme, C; Mace-Lesec'h, J; Crouet, H
      High-dose platinum versus standard dose in advanced ovarian carcinoma: A randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)

      GYNECOLOGIC ONCOLOGY
    23. Rebischung, C; Pautier, P; Morice, P; Lhomme, C; Duvillard, P
      alpha-fetoprotein production by a malignant mixed mullerian tumor of the ovary

      GYNECOLOGIC ONCOLOGY
    24. Morice, P; Viala, J; Pautier, P; Lhomme, C; Duvillard, P; Castaigne, D
      Port-site metastasis after laparoscopic surgery for gynecologic cancer - Areport of six cases

      JOURNAL OF REPRODUCTIVE MEDICINE
    25. Long, WQ; Ranchin, V; Pautier, P; Belville, C; Denizot, P; Cailla, H; Lhomme, C; Picard, JY; Bidart, JM; Rey, R
      Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    26. Pautier, P; Genestie, C; Rey, A; Morice, P; Roche, B; Lhomme, C; Haie-Meder, C; Duvillard, P
      Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma

      CANCER
    27. Lotz, JP; Lhomme, C; Pautier, P; Couteau, C; Gligorov, J; Alexandre, J; Selle, F; Izrael, V; Maraninchi, D; Viens, P
      High-dose chemotherapy in ovarian adenocarcinoma

      BULLETIN DU CANCER
    28. Lewin, M; de Baere, T; Lagrange, C; Lhomme, C; Pautier, P; Roche, A
      Cystogastric transmural drainage for the treatment of symptomatic cystic metastases from ovarian carcinoma

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    29. Lhomme, C; Fumoleau, P; Fargeot, P; Krakowski, Y; Dieras, V; Chauvergne, J; Vennin, P; Rebattu, P; Roche, H; Misset, JL; Lentz, MA; Van Glabbeke, M; Matthieu-Boue, A; Mignard, D; Chevallier, B
      Results of a European organization for research and treatment of cancer/early clinical studies group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix

      JOURNAL OF CLINICAL ONCOLOGY
    30. Morice, P; Pautier, P; Mercier, S; Spatz, A; Lhomme, C; Duvillard, P; Gerbaulet, A; Castaigne, D
      Laparoscopic prophylactic oophorectomy in women with inherited risk of ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    31. Lhomme, C; Vennin, P; Callet, N; Lesimple, T; Achard, JL; Chauvergne, J; Luporsi, E; Chinet-Charrot, P; Coudert, B; Couette, JE; Guastalla, JP; Lebrun, D; Ispas, S; Blumberg, J
      A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: A French Anticancer Federation study

      GYNECOLOGIC ONCOLOGY
    32. Haie-Meder, C; Fervers, B; Chauvergne, J; Fondrinier, E; Lhomme, C; Guastalla, JP; Resbeut, M
      Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR

      BULLETIN DU CANCER
    33. MICHEL G; MORICE P; CASTAIGNE D; LANOUX P; PAUTIER P; LHOMME C; GERBAULET A; DUVILLARD P
      STAGE-I AND STAGE-II ENDOMETRIAL CARCINOMA - PROGNOSTIC FACTORS AND SURGICAL IMPLICATIONS

      Contraception fertilite sexualite
    34. DELORD JP; FIZAZI K; ELHAJJ M; PAUTIER P; LHOMME C
      ISOLATED LEPTOMENINGEAL METASTASIS FROM OVARIAN-CARCINOMA - AN UNUSUAL EVENT

      European journal of cancer
    35. HERON JF; JOLY F; KERBRAT P; CHAUVERGNE J; MAYER F; WEBER B; CHINETCHARROT P; CROUET H; GOUPIL A; LESECH JM; LEBRUNJEZEKOVA D; NAMER M; MARTIN C; GUASTALLA JP; LHOMME C
      CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/

      Annals of oncology
    36. DELALOGE S; GOCALVEZ E; PAUTIER P; DUVILLARD P; HAIEMEDER C; GOUPIL A; MICHEL G; LHOMME C
      NEUROENDOCRINE SMALL-CELL CARCINOMA OF THE CERVIX - A RARE, AGGRESSIVE, AND CHEMORESISTANT DISEASE

      Annals of oncology
    37. CHOUAKI N; TAAMMA A; LADEM A; DELALOGE S; MISSET JL; PAUTIER P; LHOMME C; CVITKOVIC E
      FEASIBILITY TRIAL OF PACLITAXEL (PXL), OXALIPLATIN (L-OHP) AND CISPLATIN (CDDP) COMBINATION IN ADVANCED OVARIAN-CANCER PATIENTS

      Annals of oncology
    38. FLORIO P; LUISI S; CASAROSA E; GENAZZANI AR; PAUTIER P; LHOMME C; BIDART JM; DRIUL PG; PETRAGLIA F
      SERUM LEVELS OF DIMERIC ACTIVIN A ARE NOT A MARKER OF PLACENTAL TUMORS IN THE COURSE OF CHEMOTHERAPY

      Journal of endocrinological investigation
    39. PETRAGLIA F; LUISI S; PAUTIER P; SABOURIN JC; REY R; LHOMME C; BIDART JM
      INHIBIN-B IS THE MAJOR FORM OF INHIBIN ACTIVIN FAMILY SECRETED BY GRANULOSA-CELL TUMORS/

      The Journal of clinical endocrinology and metabolism
    40. Spano, JP; Lucchi, E; Sezeur, A; Lhomme, C
      Epithelial ovarian cancers (advanced stage)

      BULLETIN DU CANCER
    41. Pautier, P; Lhomme, C
      Hereditary ovarian carcinoma

      EUROCANCER 98
    42. PAUTIER P; LHOMME C; CULINE S; DUVILLARD P; MICHEL G; BIDART JM; GERBAULET A; DROZ JP
      ADULT GRANULOSA-CELL TUMOR OF THE OVARY - A RETROSPECTIVE STUDY OF 45CASES

      International journal of gynecological cancer
    43. JANIN N; LE M; LHOMME C
      INACTIVATION OF BOTH ALLELES OF BRCA1 COU LD BE OF GOOD PROGNOSIS IN OVARY ADENOCARCINOMA

      MS. Medecine sciences
    44. MICHEL G; DEIACO P; CASTAIGNE D; ELHASSAN MJ; LOBREGLIO R; LHOMME C; REY A; DUVILLARD P
      EXTENSIVE CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN-CARCINOMA

      European journal of gynaecological oncology
    45. CULINE S; LHOMME C; KATTAN J; MICHEL G; DUVILLARD P; DROZ JP
      CISPLATIN-BASED CHEMOTHERAPY IN THE MANAGEMENT OF GERM-CELL TUMORS OFTHE OVARY - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE

      Gynecologic oncology
    46. KINKEL K; ARICHE M; TARDIVON AA; SPATZ A; CASTAIGNE D; LHOMME C; VANEL D
      DIFFERENTIATION BETWEEN RECURRENT TUMOR AND BENIGN CONDITIONS AFTER TREATMENT OF GYNECOLOGIC PELVIC CARCINOMA - VALUE OF DYNAMIC CONTRAST-ENHANCED SUBTRACTION MR-IMAGING

      Radiology
    47. CULINE S; LHOMME C; DROZ JP
      MEDICAL-TREATMENT OF OVARIAN GERM-CELL MALIGNANCIES IN THE ADULT

      Bulletin du cancer
    48. PAUTIER P; REY A; MICHEL G; CASTAIGNE D; ROCHARD F; DUVILLARD P; HAIEMEDER C; CURCIO P; BENEDETTIRICHARD L; LHOMME C
      NEGATIVE 2ND-LOOK LAPAROTOMY - AN OVARIAN -CANCER ANALYSIS OF PROGNOSTIC AND SURVIVAL FACTORS BASED ON 64 CASES TREATED AT THE INSTITUT GUSTAVE-ROUSSY

      Bulletin du cancer
    49. LHOMME C; DELALOGE S; GONCALVES E; TALEA V; PAUTIER P
      ARE THERE ANY ARGUMENTS TO PROSCRIBE HORM ONE REPLACEMENT THERAPY IN WOMEN TREATED FOR OVARIAN ADENOCARCINOMA

      Bulletin du cancer
    50. SALABELLE A; RIBRAG V; NASR F; PAUTIER P; CORTI C; ELHAJJ M; LHOMME C; BAYLE C; BENNACEURGRISCELLI A
      ACTIVATED PROTEIN-C RESISTANCE IS RARELY ASSOCIATED WITH THROMBOTIC EVENTS IN PATIENTS WITH OVARIAN-CANCER

      Blood
    51. BIENVENU L; SPATZ A; DUVILLARD P; CASTAIGNE D; ROCHARD F; LHOMME C; LARTIGAU E; MAHFOUD N; MICHEL G; PRADE M
      INTRAVAGINAL AMPUTATION OF THE UTERINE CERVIX WITH FROZEN-SECTION EXAMINATION OF THE ENDOCERVICAL MARGIN - A REVIEW OF 414 CONSECUTIVE PATIENTS

      International journal of gynecological cancer
    52. LHOMME C; KERBRAT P; LEJEUNE C; GUASTALLA JP; FUMOLEAU P; GOUPIL A; HERON JF; CASSIN MA; PRUVOT I; SOARES JA; CHAZARD M
      CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY

      Seminars in oncology
    53. LHOMME C; COLLOBERTLAUGIER C; AMARDEILH MF; DELVERDIER M
      EQUINE DYSAUTONOMIA - AN ANATOMOCLINICAL STUDY OF 8 CASES

      Revue de Medecine Veterinaire
    54. CULINE S; LHOMME C; MICHEL G; LECLERE J; DUVILLARD P; DROZ JP
      IS THERE A ROLE FOR 2ND-LOOK LAPAROTOMY IN THE MANAGEMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY - EXPERIENCE AT INSTITUT-GUSTAVE-ROUSSY

      Journal of surgical oncology
    55. FARHAT F; CULINE S; LHOMME C; DUVILLARD P; SOULIE P; MICHEL G; TERRIERLACOMBE MJ; THEODORE C; SCHREINEROVA M; DROZ JP
      DESMOPLASTIC SMALL ROUND-CELL TUMORS - RESULTS OF A 4-DRUG CHEMOTHERAPY REGIMEN IN 5 ADULT PATIENTS

      Cancer
    56. LHOMME C; SCHREINEROVA M; DELORME T; MURAWADURAND S; CHAZARD M
      IS THERE A PLACE FOR CHEMOTHERAPY IN THE INITIAL TREATMENT FOR CERVICAL-CANCER - LITERATURE-REVIEW

      Bulletin du cancer
    57. REY RA; LHOMME C; MARCILLAC I; LAHLOU N; DUVILLARD P; JOSSO N; BIDART JM
      ANTIMULLERIAN HORMONE AS A SERUM MARKER OF GRANULOSA-CELL TUMORS OF THE OVARY - COMPARATIVE-STUDY WITH SERUM ALPHA-INHIBIN AND ESTRADIOL

      American journal of obstetrics and gynecology
    58. CULINE S; LHOMME C; KATTAN J; MICHEL G; DUVILLARD P; DROZ JP
      PURE MALIGNANT IMMATURE TERATOMA OF THE OVARY - THE ROLE OF CHEMOTHERAPY AND 2ND-LOOK SURGERY

      International journal of gynecological cancer
    59. CULINE S; LHOMME C; FARHAT F; DROZ JP
      SALVAGE CHEMOTHERAPY IN NON-DYSGERMINOMATOUS GERM-CELL TUMORS OF THE OVARY

      European journal of cancer
    60. HERON JF; LHOMME C; KERBRAT P; MAYER F; CHEVALLIER B; GOUPIL A; VENNIN P; LEBRUN D; CHAUVERGNE J; AYME Y; NAMER M
      HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE

      European journal of cancer
    61. LHOMME C; GUASTALLA JP; DAUPLAT J; FERRERO JM; OBERLING F; VENNIN P; POUILLART P; FUMOLEAU P; KERBRAT P; TUBIANA N; HERON JF; BUGAT R; BACHELOT T; SCHREINEROVA M; FLEURY J; NAMER M; DUFOUR P; DIERAS V; SOLARMICHEL P; PRUVOT I; CHANEZ MA; GARET F; CHAZARD M; PELLAECOSSET B
      A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC)

      European journal of cancer
    62. HAIEMEDER C; GERBAULET A; LARTIGAU E; MARSIGLIA H; LHOMME C; CASTAIGNE D
      THE ROLE OF BRACHYTHERAPY IN THE TREATMENT OF CERVICAL-CARCINOMA

      European journal of cancer
    63. CHEVALLIER B; LHOMME C; DIERAS V; CAPPELAERE P; REBATTU P; FUMOLEAU P
      A PHASE-II STUDY OF CPT-11 (IRINOTECAN) IN CHEMOTHERAPY NAIVE PATIENTS WITH ADVANCED CANCER OF THE CERVIX UTERI (CCU)

      European journal of cancer
    64. CULINE S; LHOMME C; KATTAN J; DUVILLARD P; MICHEL G; GERBAULET A; DROZ JP
      CISPLATIN-BASED CHEMOTHERAPY IN DYSGERMINOMA OF THE OVARY - 13-YEAR EXPERIENCE AT THE INSTITUT-GUSTAVE-ROUSSY

      Gynecologic oncology
    65. CULINE S; LHOMME C; DROZ JP
      UNTITLED - REPLY

      Gynecologic oncology
    66. FAJAC A; BENARD J; LHOMME C; REY A; DUVILLARD P; ROCHARD F; BERNAUDIN JF; RIOU G
      C-ERBB2 GENE AMPLIFICATION AND PROTEIN EXPRESSION IN OVARIAN EPITHELIAL TUMORS - EVALUATION OF THEIR RESPECTIVE PROGNOSTIC-SIGNIFICANCE BY MULTIVARIATE-ANALYSIS

      International journal of cancer
    67. FARHAT F; CULINE S; LHOMME C; DUVILLARD P; TERRIERLACOMBE MJ; MICHEL G; SOULIE P; THEODORE C; LOTZ JP; DROZ JP
      ADULT DESMOPLASTIC SMALL ROUND-CELL TUMOR S - A NEW ENTITY

      Bulletin du cancer
    68. PAUTIER P; BIDART JM; LALLOU N; DUVILLARD P; MICHEL G; DROZ JP; LHOMME C
      INHIBIN AS A MARKER IN GRANULOSA-CELL TUM ORS, STUDIED IN 6 ADDITIONAL CASES TREATED AT THE INSTITUT-GUSTAVE-ROUSSY

      Bulletin du cancer
    69. GERBAULET A; LARTIGAU E; HAIEMEDER C; MICHEL G; PRADE M; LHOMME C
      CERVIX CARCINOMA IN YOUNG-WOMEN

      Contraception fertilite sexualite
    70. CULINE S; LHOMME C; KATTAN J; DUVILLARD P; MICHEL G; DROZ JP
      LONG-TERM RESULTS OF 2 VAB-LIKE REGIMENS (VINBLASTINE PLUS ACTINOMYCIN-D PLUS BLEOMYCIN PLUS CYCLOPHOSPHAMIDE PLUS CISPLATIN) IN MALIGNANT GERM-CELL TUMORS OF THE OVARY

      European journal of cancer
    71. GUASTALLA JP; LHOMME C; KERBRAT P; MAYER F; NAMER M; GOUPIL P; CHARROT P; HERON JF; CHAZARD M; RICHARD I; CHAUVIN F
      PHASE-II TRIAL OF INTRAPERITONEAL CARBOPLATIN IN OVARIAN-CARCINOMA PATIENTS WITH MACROSCOPIC RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY

      Annals of oncology
    72. LARTIGAU E; HAIEMEDER C; CASTAIGNE D; MICHEL G; DUVILLARD P; LHOMME C; GERBAULET A
      CANCER OF THE CERVIX UTERI - THE EXPERIEN CE OF GUSTAVE-ROUSSY-INSTITUTE

      Pathologie et biologie
    73. LHOMME C; DELORME T
      1ST LINE CHEMOTHERAPY IN OVARIAN ADENOCAR CINOMAS

      Pathologie et biologie
    74. ROJASVELARDE L; LHOMME C
      PIOUS INTENTIONS + BOLIVIAN VILLAGERS PROTEST AGAINST TOXIC DUMPING

      Index on censorship
    75. CULINE S; KATTAN J; LHOMME C; DUVILLARD P; MICHEL G; CASTAIGNE D; LECLERE J; PICO J; DROZ JP
      A PHASE-II STUDY OF HIGH-DOSE CISPLATIN, VINBLASTINE, BLEOMYCIN, AND ETOPOSIDE (PVEBV REGIMEN) IN MALIGNANT NONDYSGERMINOMATOUS GERM-CELL TUMORS OF THE OVARY

      Gynecologic oncology
    76. CHAUVERGNE J; LHOMME C; ROHART J; HERON JF; AYME Y; GOUPIL A; FARGEOT P; DAVID M
      NEOADJUVANT CHEMOTHERAPY FOR STAGES IIB-I II CERVICAL CANCERS - LONG-TERM FOLLOW-UP OF PLURICENTRIC RANDOMIZED STUDY OF 151 PATIENTS

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 00:58:34